INTERACTION |
ID |
lncRNA Name |
Interaction target |
Level of interaction |
Type of interaction |
Description |
PMID |
Source |
EL1171 |
RRP1B |
PARP1 |
RNA-Protein |
binding |
However, it is highly unlikely that the RRP1B-PARP1 interaction is an experimental artifact, since there is loss of binding with the ΔC-term sample. |
19710015 |
LncRNADisease
|
EL1171 |
RRP1B |
CSDA |
RNA-Protein |
binding |
Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A). |
19710015 |
LncRNADisease
|
EL1171 |
RRP1B |
H1X |
RNA-Protein |
binding |
Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A). |
19710015 |
LncRNADisease
|
EL1171 |
RRP1B |
TRIM28 |
RNA-Protein |
binding |
Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A). |
19710015 |
LncRNADisease
|
EL1171 |
RRP1B |
Cisplatin and paclitaxel |
N/A |
regulation |
Cisplatin and paclitaxel have target function on significant lncRNAs in LSCC, which presents novel molecular targets to cure LSCC patients and also leads an orientation for developing new drugs. |
25257554 |
|
|